www.easilymeds2.com
- US Toll free:
- Regular US:
- UK:
- Categories list
-
- Alcoholism
- Alzheimer's And Parkinson's
- Analgesics
- Anti-inflammatories
- Antiallergic
- Antibiotics
- Anticonvulsants
- Antidepressants
- Antifungals
- Antiparasitic
- Antivirals
- Arthritis
- Asthma
- Birth Control
- Cancer
- Cardiovascular Diseases
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Care
- Gastrointestinal Tract
- HIV
- Hypertension
- Men's Health
- Mental Disorders
- Migraine
- Muscle Relaxants
- Neurological Disorders
- Obesity
- Osteoporosis
- Respiratory Tract
- Skin Care
- Surgery
- Urinary Tract
- Women's Health
Generic Omeprazole - Prilosec
Generic Prilosec
Generic Prilosec is used for treating heartburn or irritation of the esophagus caused by gastroesophageal reflux disease (GERD). It may also be used for short-term treatment of ulcers of the stomach or small intestines and to help prevent them from coming back; to treat conditions that cause your body to make too much stomach acid (eg, Zollinger-Ellison syndrome).
$0.69
Buy now!
Choose Your language:
- Testimonials
-
Hi.
Read more »
just want to say thanks for your promt and efficient service.. The tablets arrived well within the timeframe given.. Have passed on your address, dont know wheather its been used or not..
Best regards... and happy St Patricks from the Irish in France.. - Kieran
-
- PA32540 Provides Faster Gastric Acid Reduction Than Enteric-Coated Omeprazole ... - MarketWatch (press release)
- PA32540 Provides Faster Gastric Acid Reduction Than Enteric-Coated Omeprazole
- Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in ... - MarketWatch (press release)
- Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in
- Pernix Therapeutics introduces Omeclamox-Pak® for the treatment of H. pylori ... - News-Medical.net
- Pernix Therapeutics introduces Omeclamox-Pak® for the treatment of H
- POZEN Reports PA32540 / PA8140 Updates and First Quarter 2012 Financial Results - MarketWatch (press release)
- POZEN Reports PA32540 / PA8140 Updates and First Quarter 2012 Financial ResultsMarketWatch (press release)POZEN announced positive top-line results from two randomized, double-blind, multi-center, pivotal Phase 3 clinical trials of PA32540, a novel, coordinated-delivery tablet of immediate-release omeprazole (40 mg) and delayed release aspirin (325 mg)
- Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with ... - 7thSpace Interactive (press release)
- Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with
 |
Bookmark this site |
|---|
 |
Subscribe to the News |
|---|
